Like the 66% completion rate. Is a 144.5 rating good?
Cliff notes summary please
So maybe the question becomes are we better with a senior Mills than a sophomore Max? Why would we turn down a 6'4" senior who was a 5* in high school, and obviously sharp as a tack?
I doubt we turn him down. My guess, is that we got more interested in QBs from B10/Pac12 after Duggan heart discovery last week.
Not sure how we use grey shirt to make scholarship room for him but there several routes.
Also not sure how Duggan plays out if they’re both here. I think we would get medical redshirt since he’s only playing half the season and still had redshirt available
I doubt we turn him down. My guess, is that we got more interested in QBs from B10/Pac12 after Duggan heart discovery last week.
Not sure how we use grey shirt to make scholarship room for him but there several routes.
Also not sure how Duggan plays out if they’re both here. I think we would get medical redshirt since he’s only playing half the season and still had redshirt available
I doubt we turn him down. My guess, is that we got more interested in QBs from B10/Pac12 after Duggan heart discovery last week.
Not sure how we use grey shirt to make scholarship room for him but there several routes.
Also not sure how Duggan plays out if they’re both here. I think we would get medical redshirt since he’s only playing half the season and still had redshirt available
We have open scholarships. We didn’t fill.
I’ve sold a few mAb’s including a PCSK9 Inhibitor. I’ve also worked with one of the companies that is in Phase 3 mAb trial presently for a COVID-blocking mAb. While I’m not involved at all in that, I do know a bit about mAb’s in general and how they work. Here’s a link to a 2:30m video that explains how a PCSK9 inhibitor works to reduce cholesterol. I imagine that the mAbs being researched for COVID would work by binding to a receptor site on the virus and preventing it from entering cells or attaching to them. mAbs are lab generated proteins that mimic ones that are naturally occurring. The video will demonstrate how a mAb works on an LDL receptor.